JP2009530393A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530393A5
JP2009530393A5 JP2009501562A JP2009501562A JP2009530393A5 JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5 JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5
Authority
JP
Japan
Prior art keywords
monocyclic
compound
alkyl
bicyclic
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009501562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/007146 external-priority patent/WO2007111954A2/en
Publication of JP2009530393A publication Critical patent/JP2009530393A/ja
Publication of JP2009530393A5 publication Critical patent/JP2009530393A5/ja
Withdrawn legal-status Critical Current

Links

JP2009501562A 2006-03-23 2007-03-22 プリン化合物およびその使用方法 Withdrawn JP2009530393A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78509306P 2006-03-23 2006-03-23
US78501406P 2006-03-23 2006-03-23
US78509206P 2006-03-23 2006-03-23
US78509406P 2006-03-23 2006-03-23
PCT/US2007/007146 WO2007111954A2 (en) 2006-03-23 2007-03-22 Purine compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009530393A JP2009530393A (ja) 2009-08-27
JP2009530393A5 true JP2009530393A5 (https=) 2010-05-06

Family

ID=38541654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009501562A Withdrawn JP2009530393A (ja) 2006-03-23 2007-03-22 プリン化合物およびその使用方法

Country Status (10)

Country Link
US (1) US20070238694A1 (https=)
EP (1) EP1996020A4 (https=)
JP (1) JP2009530393A (https=)
KR (1) KR20080110816A (https=)
AU (1) AU2007229463A1 (https=)
BR (1) BRPI0709124A2 (https=)
CA (1) CA2643503A1 (https=)
IL (1) IL193693A0 (https=)
MX (1) MX2008012185A (https=)
WO (1) WO2007111954A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
CN101437526A (zh) * 2004-09-20 2009-05-20 伊诺泰克制药公司 嘌呤衍生物及其用法
EA015683B1 (ru) * 2005-11-30 2011-10-31 Инотек Фармасьютикалз Корпорейшн Производные пурина и способы их применения
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2011053569A1 (en) * 2009-10-26 2011-05-05 Inotek Pharmaceuticals Corporation Ophthalmic formulation and method of manufacture thereof
LT2523669T (lt) 2010-01-11 2017-04-25 Inotek Pharmaceuticals Corporation Akispūdžio mažinimo būdas, derinys ir rinkinys
PH12012501906A1 (en) * 2010-03-26 2013-01-14 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
PT2807178T (pt) 2012-01-26 2017-08-08 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de (2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-dihidroxitetrahidrofuran-2-il)}metilo e seus processos de preparação
KR20150138182A (ko) * 2013-03-15 2015-12-09 이노텍 파마슈티컬스 코포레이션 안구 신경보호를 제공하는 방법
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
AU2003232071A1 (en) * 2002-05-06 2003-11-17 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
CN101437526A (zh) * 2004-09-20 2009-05-20 伊诺泰克制药公司 嘌呤衍生物及其用法

Similar Documents

Publication Publication Date Title
JP2009530393A5 (https=)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2009504763A5 (https=)
JP2005518350A5 (https=)
JP2013509411A5 (https=)
WO2012138894A4 (en) Hsp90 inhibitors
JP2003506354A5 (https=)
JP2012525393A5 (https=)
JPWO2019195124A5 (https=)
JP2009513658A5 (https=)
JP2010501584A5 (https=)
JP2008545793A5 (https=)
JP2017526677A5 (https=)
JP2000256194A (ja) 核内レセプタ作動薬およびその効果増強剤
JP2019515908A5 (https=)
JP2006507220A5 (https=)
JP2007501779A5 (https=)
CA2303815A1 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
RU2014109441A (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
JP2010522710A5 (https=)
JP2007515476A5 (https=)
JP2008510758A5 (https=)
JP2020524178A5 (https=)
RU2016116789A (ru) Комбинация энзалутамида и афурезертиба для лечения рака
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом